95 related articles for article (PubMed ID: 25555365)
1. miR-210 is a prognostic marker in clear cell renal cell carcinoma.
Samaan S; Khella HW; Girgis A; Scorilas A; Lianidou E; Gabril M; Krylov SN; Jewett M; Bjarnason GA; El-said H; Yousef GM
J Mol Diagn; 2015 Mar; 17(2):136-44. PubMed ID: 25555365
[TBL] [Abstract][Full Text] [Related]
2. Global and Targeted miRNA Expression Profiling in Clear Cell Renal Cell Carcinoma Tissues Potentially Links miR-155-5p and miR-210-3p to both Tumorigenesis and Recurrence.
Zhang J; Ye Y; Chang DW; Lin SH; Huang M; Tannir NM; Matin S; Karam JA; Wood CG; Chen ZN; Wu X
Am J Pathol; 2018 Nov; 188(11):2487-2496. PubMed ID: 30201497
[TBL] [Abstract][Full Text] [Related]
3. Impact of miR-21, miR-126 and miR-221 as prognostic factors of clear cell renal cell carcinoma with tumor thrombus of the inferior vena cava.
Vergho DC; Kneitz S; Kalogirou C; Burger M; Krebs M; Rosenwald A; Spahn M; Löser A; Kocot A; Riedmiller H; Kneitz B
PLoS One; 2014; 9(10):e109877. PubMed ID: 25279769
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of meta-signature miRNAs in renal cell carcinoma: an integrated miRNA expression profiling analysis.
Tang K; Xu H
Sci Rep; 2015 May; 5():10272. PubMed ID: 25974855
[TBL] [Abstract][Full Text] [Related]
5. SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization.
Ferreira MJ; Pires-Luís AS; Vieira-Coimbra M; Costa-Pinheiro P; Antunes L; Dias PC; Lobo F; Oliveira J; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
Epigenetics; 2017; 12(12):1057-1064. PubMed ID: 29099276
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive proteogenomic characterization of rare kidney tumors.
Li GX; Chen L; Hsiao Y; Mannan R; Zhang Y; Luo J; Petralia F; Cho H; Hosseini N; Leprevost FDV; Calinawan A; Li Y; Anand S; Dagar A; Geffen Y; Kumar-Sinha C; Chugh S; Le A; Ponce S; Guo S; Zhang C; Schnaubelt M; Al Deen NN; Chen F; Caravan W; Houston A; Hopkins A; Newton CJ; Wang X; Polasky DA; Haynes S; Yu F; Jing X; Chen S; Robles AI; Mesri M; Thiagarajan M; An E; Getz GA; Linehan WM; Hostetter G; Jewell SD; Chan DW; Wang P; Omenn GS; Mehra R; Ricketts CJ; Ding L; Chinnaiyan AM; Cieslik MP; Dhanasekaran SM; Zhang H; Nesvizhskii AI;
Cell Rep Med; 2024 May; 5(5):101547. PubMed ID: 38703764
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma.
Lasseigne BN; Burwell TC; Patil MA; Absher DM; Brooks JD; Myers RM
BMC Med; 2014 Dec; 12():235. PubMed ID: 25472429
[TBL] [Abstract][Full Text] [Related]
8. Accurate molecular classification of renal tumors using microRNA expression.
Fridman E; Dotan Z; Barshack I; David MB; Dov A; Tabak S; Zion O; Benjamin S; Benjamin H; Kuker H; Avivi C; Rosenblatt K; Polak-Charcon S; Ramon J; Rosenfeld N; Spector Y
J Mol Diagn; 2010 Sep; 12(5):687-96. PubMed ID: 20595629
[TBL] [Abstract][Full Text] [Related]
9. Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness.
Li Y; Lih TM; Dhanasekaran SM; Mannan R; Chen L; Cieslik M; Wu Y; Lu RJ; Clark DJ; Kołodziejczak I; Hong R; Chen S; Zhao Y; Chugh S; Caravan W; Naser Al Deen N; Hosseini N; Newton CJ; Krug K; Xu Y; Cho KC; Hu Y; Zhang Y; Kumar-Sinha C; Ma W; Calinawan A; Wyczalkowski MA; Wendl MC; Wang Y; Guo S; Zhang C; Le A; Dagar A; Hopkins A; Cho H; Leprevost FDV; Jing X; Teo GC; Liu W; Reimers MA; Pachynski R; Lazar AJ; Chinnaiyan AM; Van Tine BA; Zhang B; Rodland KD; Getz G; Mani DR; Wang P; Chen F; Hostetter G; Thiagarajan M; Linehan WM; Fenyö D; Jewell SD; Omenn GS; Mehra R; Wiznerowicz M; Robles AI; Mesri M; Hiltke T; An E; Rodriguez H; Chan DW; Ricketts CJ; Nesvizhskii AI; Zhang H; Ding L;
Cancer Cell; 2023 Jan; 41(1):139-163.e17. PubMed ID: 36563681
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic, prognostic, and therapeutic potential of exosomal microRNAs in renal cancer.
Yu X; Du Z; Zhu P; Liao B
Pharmacol Rep; 2024 Apr; 76(2):273-286. PubMed ID: 38388810
[TBL] [Abstract][Full Text] [Related]
11. miRNAs in Prediction of Prognosis in Clear Cell Renal Cell Carcinoma.
Ran L; Liang J; Deng X; Wu J
Biomed Res Int; 2017; 2017():4832931. PubMed ID: 29392135
[TBL] [Abstract][Full Text] [Related]
12. Overall landscape and prognostic value of the splicing factor 3 complex in clear-cell renal cell carcinoma.
Zhang J; Wei D; Liang J; Sun Z
Asian J Surg; 2023 Dec; 46(12):5573-5574. PubMed ID: 37591755
[No Abstract] [Full Text] [Related]
13. Elevated Plasma Concentration of 4-Pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR) Highlights Malignancy of Renal Cell Carcinoma.
Jedrzejewska A; Jablonska P; Gawlik-Jakubczak T; Czajkowski M; Maszka P; Mierzejewska P; Smolenski RT; Slominska EM
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397036
[TBL] [Abstract][Full Text] [Related]
14. Identification of ANKRD13D as a potential target in renal cell carcinomas.
Zhou W; Huang Y; Liu J; Liu Y; Liu Y; Yu C
Int J Biol Markers; 2024 Jun; 39(2):149-157. PubMed ID: 38449090
[TBL] [Abstract][Full Text] [Related]
15. Low expression of miR-126 is a prognostic marker for metastatic clear cell renal cell carcinoma.
Khella HW; Scorilas A; Mozes R; Mirham L; Lianidou E; Krylov SN; Lee JY; Ordon M; Stewart R; Jewett MA; Yousef GM
Am J Pathol; 2015 Mar; 185(3):693-703. PubMed ID: 25572155
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel long non-coding RNAs in clear cell renal cell carcinoma.
Blondeau JJ; Deng M; Syring I; Schrödter S; Schmidt D; Perner S; Müller SC; Ellinger J
Clin Epigenetics; 2015; 7(1):10. PubMed ID: 25685243
[TBL] [Abstract][Full Text] [Related]
17. Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting.
Beuselinck B; Job S; Becht E; Karadimou A; Verkarre V; Couchy G; Giraldo N; Rioux-Leclercq N; Molinié V; Sibony M; Elaidi R; Teghom C; Patard JJ; Méjean A; Fridman WH; Sautès-Fridman C; de Reyniès A; Oudard S; Zucman-Rossi J
Clin Cancer Res; 2015 Mar; 21(6):1329-39. PubMed ID: 25583177
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts promote renal cell carcinoma progression.
Xu Y; Lu Y; Song J; Dong B; Kong W; Xue W; Zhang J; Huang Y
Tumour Biol; 2015 May; 36(5):3483-8. PubMed ID: 25613067
[TBL] [Abstract][Full Text] [Related]
19. pVHL/HIF-regulated CD70 expression is associated with infiltration of CD27+ lymphocytes and increased serum levels of soluble CD27 in clear cell renal cell carcinoma.
Ruf M; Mittmann C; Nowicka AM; Hartmann A; Hermanns T; Poyet C; van den Broek M; Sulser T; Moch H; Schraml P
Clin Cancer Res; 2015 Feb; 21(4):889-98. PubMed ID: 25691774
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-9 is required for vasculogenic mimicry by clear cell renal carcinoma cells.
Lin H; Pan JC; Zhang FM; Huang B; Chen X; Zhuang JT; Wang H; Mo CQ; Wang DH; Qiu SP
Urol Oncol; 2015 Apr; 33(4):168.e9-16. PubMed ID: 25618297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
